TNAX Biopharma株式会社
ActiveTNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.
What it does
"TNAX Biopharma is a Medtech company dedicated to discovering valuable pharmaceutical drugs that target interactions between immune receptors and their ligands, aiming to enhance the quality of life for patients with challenging diseases. Focused on addressing unmet medical needs in patients with difficult-to-treat conditions, TNAX Biopharma specializes in the development and commercialization of innovative antibody therapies. Founded by Dr. Akira Shibutani, a renowned scientist who discovered unique immune receptors and their ligands with crucial roles in immunity and inflammation, TNAX Biopharma collaborates with Tsukuba University to leverage exclusive intellectual property rights for potential therapeutic targets. Through groundbreaking drug discovery and strategic partnerships, TNAX continues to contribute to society by providing truly valuable treatments to patients worldwide."
Its site says now · captured 2026-08-23
TNAX Biopharma Corporation |
TNAX Biopharma Corporation
Next to it in Healthcare and bio · Antibody therapeutics for immune disorders
- Tradewind BioScienceY Combinator W18
Tradewind translates scientific insight into innovative ways of…
- AutoPhagyGO Inc.Plug and Play
AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.
- セレイドセラピューティクス株式会社Plug and Play
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- 株式会社FerroptoCurePlug and Play
FerroptoCure specializes in ferroptosis research and the development of effective therapeutic drugs to treat cancer and other diseases.
- イムノジェネテクス株式会社Plug and Play
ImmunoGeneTeqs provides inflammation/immune disease control methods based on innovative gene analysis technology.
- イミュニティリサーチ株式会社Plug and Play
ImmuniT Research specializes in the research and development of immune checkpoint inhibitors.
- 株式会社PURMX TherapeuticsPlug and Play
PURMX is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
- Turn BiotechnologiesPlug and Play
Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases. Utilizing a patented mRNA platform technology, ERA, the company is combating the effects of aging on the epigenome. The company’s proprietary mRNA platform technology, ERA and eTurna, a delivery platf...